Isabel Veiga
Overview
Explore the profile of Isabel Veiga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
394
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pinheiro M, Peixoto A, Rocha P, Santos C, Escudeiro C, Veiga I, et al.
Pharmacogenet Genomics
. 2023 Aug;
33(8):165-171.
PMID: 37611150
Objectives: Genetic variants in the dihydropyrimidine dehydrogenase (DPYD ) gene are associated with reduced dihydropyrimidine dehydrogenase enzyme activity and can cause severe fluoropyrimidine-related toxicity. We assessed the frequency of the...
2.
Pinheiro M, Peixoto A, Rocha P, Veiga I, Pinto C, Santos C, et al.
Int J Colorectal Dis
. 2022 Mar;
37(4):895-905.
PMID: 35303157
Purpose: Mutations in the KRAS and NRAS (RAS) genes are negative predictors of response to anti-EGFR therapy in metastatic colorectal cancer (mCRC). The detection of mutations in circulating tumor DNA...
3.
Pinheiro M, Francisco I, Pinto C, Peixoto A, Veiga I, Filipe B, et al.
Genes Chromosomes Cancer
. 2019 Apr;
58(9):657-664.
PMID: 30968502
The mutational spectrum of the MMR genes is highly heterogeneous, but specific mutations are observed at high frequencies in well-defined populations or ethnic groups, due to founder effects. The MSH2...
4.
Guerra J, Pinto C, Pinto D, Pinheiro M, Silva R, Peixoto A, et al.
Cancer Med
. 2017 Oct;
6(12):2966-2971.
PMID: 29072370
Despite all the knowledge already gathered, the picture of somatic genetic changes in colorectal tumorigenesis is far from complete. Recently, germline and somatic mutations in the exonuclease domain of polymerase...
5.
Paulo P, Pinto P, Peixoto A, Santos C, Pinto C, Rocha P, et al.
J Mol Diagn
. 2017 May;
19(4):502-513.
PMID: 28529006
Despite the growing knowledge of the genetic background behind the cancers that occur in a context of hereditary predisposition, personal or family cancer history may not be clear enough to...
6.
Cabreira V, Pinto C, Pinheiro M, Lopes P, Peixoto A, Santos C, et al.
Fam Cancer
. 2016 Sep;
16(1):73-81.
PMID: 27581132
Lynch syndrome (LS) accounts for up to 4 % of all colorectal cancers (CRC). Detection of a pathogenic germline mutation in one of the mismatch repair genes is the definitive...
7.
Pinto P, Paulo P, Santos C, Rocha P, Pinto C, Veiga I, et al.
Breast Cancer Res Treat
. 2016 Aug;
159(2):245-56.
PMID: 27553368
Molecular diagnosis of hereditary breast and ovarian cancer (HBOC) by standard methodologies has been limited to the BRCA1 and BRCA2 genes. With the recent development of new sequencing methodologies, the...
8.
Pinto C, Pinheiro M, Peixoto A, Santos C, Veiga I, Rocha P, et al.
J Hum Genet
. 2015 Oct;
61(2):151-6.
PMID: 26446363
The majority of pathogenic mismatch repair (MMR) gene mutations detected in Lynch syndrome patients are truncating (frameshift or nonsense). However, the classification of terminal truncating mutations is sometimes difficult and...
9.
Pinheiro M, Pinto C, Peixoto A, Veiga I, Lopes P, Henrique R, et al.
Br J Cancer
. 2015 Aug;
113(4):686-92.
PMID: 26247575
Background: We previously reported that the target genes in sporadic mismatch repair (MMR)-deficient colorectal carcinomas (CRCs) in the distal colon differ from those occurring elsewhere in the colon. This study...
10.
Botelho M, Veiga I, Oliveira P, Lopes C, Teixeira M, Costa J, et al.
Adv Cancer Res Treat
. 2014 Sep;
2013.
PMID: 25221779
is a parasitic flatworm that infects millions of people, mostly in the developing world, and is associated with high incidence of bladder cancer, although why is not clear. Previously, we...